Science Explorer Back to mapMap
Discussion
Researcher · Chinese University of Hong Kong · China

Stephen Lam Chan

Stephen Lam Chan publishes mostly in Hepatology, Oncology and Molecular Biology, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cancer Immunotherapy and Biomarkers and Cholangiocarcinoma and Gallbladder Cancer Studies.

ORCID 0000-0001-8998-5480 OpenAlex
World rank
#47,819
of 7,710,434 ranked researchers
Rank in China
#3,467
of 978,568
Works
724
Citations
37k
Citations per work
50.8
h-index
84
i10-index 263Top 0.9% in Hepatology
Stephen Lam Chan

What does Stephen Lam Chan research?

Stephen Lam Chan's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 459 works · 63.4% of their workMedicine: 459 works · 63.4% of their workHepatology: 155 works · 21.4% of their workOncology: 131 works · 18.1% of their workEpidemiology: 62 works · 8.6% of their workSurgery: 56 works · 7.7% of their workPulmonary and Respiratory Medicine: 55 works · 7.6% of their workEverything else: 201 works · 27.7% of their workLife Sciences: 64 works · 8.9% of their workBiochemistry, Genetics and Molecular Biology: 64 works · 8.9% of their workMolecular Biology: 64 works · 8.9% of their workTHEIR WORKStephen Lam Chan724works
Life Sciences9%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine45963.4%
  2. Everything else20127.7%
    1. Biochemistry, Genetics and Molecular Biology648.9%
  1. 1Hepatology21% of their works
  2. 2Oncology18% of their works
  3. 3Molecular Biology9% of their works
  4. 4Epidemiology9% of their works
  5. 5Surgery8% of their works
  6. 6Pulmonary and Respiratory Medicine8% of their works

Research topics

Which keywords describe Stephen Lam Chan's research?

The keywords of their largest research topics: Hepatocellular Carcinoma, Liver Cancer, Management, Tumor Microenvironment, Chemotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1 and Biliary Tract Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Hepatocellular Carcinoma3953 topics
  2. Liver Cancer2731 topic
  3. Management2731 topic
  4. Tumor Microenvironment1552 topics
  5. Chemotherapy1032 topics
  6. Immune Checkpoint Blockade931 topic
  7. PD-1 and PD-L1931 topic
  8. Biliary Tract Cancer861 topic
  9. Cholangiocarcinoma861 topic
  10. NAFLD811 topic
  11. NASH811 topic
  12. Pancreatic Cancer621 topic
  13. Surgical Complications621 topic
  14. Cetuximab411 topic
  15. Chronic Hepatitis B411 topic
  16. Hepatitis B Virus411 topic
  17. KRAS Mutations411 topic
  18. Pim Oncogenes411 topic
  19. Tumorigenesis411 topic

Where does Stephen Lam Chan work?

Stephen Lam Chan's main affiliation in the publication record is Chinese University of Hong Kong, China.

How many publications and citations does Stephen Lam Chan have?

OpenAlex counts 724 works and 36,755 citations for Stephen Lam Chan, an h-index of 84, ranking #47,819 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stephen Lam Chan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.